Vancomycin Screen Agar — Class II medical device recall Z-0473-2016
Terminated recall by Becton Dickinson & Co., reported 2015-12-30, distributed nationwide. The affected expired lots of product may have exhibited breakthrough growth of vancomycin susceptible Enteroco
| Recall number | Z-0473-2016 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Co., Sparks, MD, United States |
| Recall initiated | 2015-06-29 |
| Classified | 2015-12-23 |
| Reported by FDA | 2015-12-30 |
| Terminated | 2016-08-12 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, CO, IN, MX |
| Quantity | 60,840 |
| Lot numbers | 5041659, 5064921, 5076659, 5083712, 5097504, 5105955, 5130907, 5139626, 5147941 |
| Model numbers | 222204 |
Product
Vancomycin Screen Agar
Reason for recall
The affected expired lots of product may have exhibited breakthrough growth of vancomycin susceptible Enterococcus facaelis ATCC 29212 near the end of shelf life. The in-date product may also exhibit breakthrough growth of vancomycin susceptible Enterococcus facaelis ATCC 29212 near the end of shelf life.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0473-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.